文献速递炎症性肠病

非裔美国人与白人克罗恩病患者术后复发风险的比较

A comparison of the risk of postoperative recurrence between African-American and Caucasian patients with Crohn's disease.
PubMed 文献 · Aliment Pharmacol Ther · 2018-08-20

本研究回顾2014年6月至2016年6月接受手术的克罗恩病患者病历,比较非裔美国人与白人术后6-12个月临床及内镜缓解情况,发现内镜缓解率无差异,但非裔美国人临床缓解率显著更低,且与非裔美国人种族显著相关。

要点

  • 非裔美国人克罗恩病患者术后临床缓解率显著低于白人(36% vs 63%,P=0.008)。
  • 内镜缓解率在两组间无显著差异(50% vs 42%,P=0.76)。
  • 非裔美国人种族与临床复发显著相关(倾向匹配分析68% vs 32%,P=0.005)。

核心结论

  • 非裔美国人克罗恩病患者术后黏膜炎症的客观指标(包括内镜复发)与白人相似,但非裔美国人种族与临床复发显著相关,提示术后表现存在种族差异。

研究设计与样本

  • 回顾性病历审查,纳入2014年6月至2016年6月接受回肠、结肠或回结肠切除的克罗恩病患者,非裔美国人36例、白人167例。
  • 主要终点为术后6-12个月临床及内镜缓解,次要终点包括生物学及组织学缓解,采用单因素、多因素及倾向评分匹配分析评估复发风险。

主要发现

  • 内镜缓解率非裔美国人与白人无显著差异(50% vs 42%,P=0.76),种族在内镜复发风险的单因素、多因素或倾向评分匹配分析中均无影响。
  • 临床缓解率非裔美国人显著低于白人(36% vs 63%,P=0.008)。
  • 非裔美国人种族与临床复发显著相关:单因素分析(OR 6.76,95%CI 1.50-30.40;P=0.01)、多因素分析(OR 5.02,95%CI 1.60-15.80;P=0.006)、倾向匹配分析(非裔美国人68% vs 白人32%,P=0.005)。
  • 生物学及组织学缓解率在所有分析中两组均相似。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Many patients with Crohn's disease will develop complications that require surgery. Recurrence after surgery is common. AIM: To assess racial differences in postoperative recurrence between African-Americans and Caucasians. METHODS: Medical records of Crohn's disease patients who underwent surgery (ileal, colonic, or ileocolonic resection) between June 2014 and June 2016 were reviewed. The primary endpoints were clinical and endoscopic remission at 6-12 months after a Crohn's disease surgery. Secondary outcomes included biological and histologic remission. Risks of recurrence were assessed by univariate, multivariate, and propensity score-matched analysis. RESULTS: Thirty-six African-American and 167 Caucasian patients with Crohn's disease were included for analysis. There was no difference in disease location, disease behaviour, type of surgery performed, and pre- or postoperative medication use between the two groups. The rate of endoscopic remission did not differ between African-American and Caucasian patients (50% vs 42%, P = 0.76), and race did not influence the risk of endoscopic recurrence on univariate, multivariate, or propensity score-matched analysis. The rate of clinical remission was significantly lower in African-American patients compared to Caucasian patients (36% vs. 63%, P = 0.008). African-American race was significantly associated with clinical recurrence on univariate (odds ratio (OR) 6.76, 95% CI 1.50-30.40; P = 0.01), multivariate (OR 5.02, 95% CI 1.60-15.80; P = 0.006), and propensity-matched analysis (68% vs. 32% in Caucasians, P = 0.005). Rates of biologic and histologic remission were similar between the two groups on all analyses. CONCLUSIONS: We found that African-American patients with Crohn's disease have a similar degree of objective measures of mucosal inflammation after surgery including endoscopic recurrence as compared to Caucasian patients. However, African-American race was significantly associated with clinical recurrence, suggesting the presence of ethnic variation in postoperative presentation in Crohn's disease.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Anyane-Yeboa A, Yamada A, Haider H, et al. A comparison of the risk of postoperative recurrence between African-American and Caucasian patients with Crohn's disease. Aliment Pharmacol Ther. 2018. PMID: 30126019. doi:10.1111/apt.14951

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。